Global Synthetic Biology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing) Market - Forecast to 2018


Dublin, Dec. 3, 2014 (GLOBE NEWSWIRE) -- Research and Markets ( has announced the addition of the "Synthetic Biology Market by Tool, Technology, Application - Global Forecast to 2018" report to their offering.

The synthetic biology market is highly competitive with a large number of players, including both big and small players, operating in this market. Synthetic biology is an emerging area of research and is broadly described as the design and construction of novel organisms or devices, artificial biological pathways, and the redesign of existing natural biological systems.

The global synthetic biology market is segmented on the basis of tools, technologies, applications, and regions. On the basis of tools, the market is categorized into Xeno-nucleic acids, chassis organisms, oligonucleotides, enzymes, and cloning and assembly kits. The oligonucleotides segment is expected to account for the largest share of the synthetic biology market, by tool. However, the cloning and assembly kits segment is expected to grow at the fastest rate in the market, by tool.

On the basis of technologies, the synthetic biology market is segmented into enabling and enabled technologies. Enabling technologies account is the largest and fastest-growing segment of the market, by technology.

On the basis of applications, the synthetic biology market is segmented into environmental, medical, and industrial applications. Medical application is the largest (2013) and fastest-growing segment of the market, by application.

The key factors that are expected to spur the growth of this market are increasing R&D expenditure in pharmaceutical and biotechnology companies, growing demand for synthetic genes, rising production of genetically modified crops, and incessantly rising funding in this field. However, ethical and social issues such as biosafety and biosecurity of synthetic biology are hindering the growth of this market.

On the basis of region, this market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).

The global synthetic biology market is expected to reach $5,630.4 million in 2018 from $1,923.1 million in 2013, growing at a CAGR of 24%. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). Europe is expected to dominate the market in terms of the value by 2018.

Some of the major players in the global market include Amyris, Inc. (U.S.), DuPont (U.S.), GenScript USA Inc. (U.S.), Intrexon Corporation (U.S.), Integrated DNA Technologies (IDT) (U.S.), New England Biolabs, Inc. (NEB) (U.S.), Novozymes (Denmark), Royal DSM (Netherlands), Synthetic Genomics, Inc. (California), and Thermo Fisher Scientific, Inc. (U.S.).

Key Topics Covered:

1 Introduction

2 Research Methodology (Page No.19)

3 Executive Summary

4 Premium Insights

5 Industry Speaks

6 Market Overview

7 Industry Insights

8 Synthetic Biology Market, By Tool

9 Market, By Technology

10 Market, By Application

11 Synthetic Biology Market, By Geography

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned:

  • Amyris, Inc.
  • Dupont
  • Genscript USA, Inc.
  • Integrated Dna Technologies (IDT), Inc.
  • Intrexon Corporation
  • New England Biolabs, Inc.
  • Novozymes
  • Royal DSM N.V.
  • Synthetic Genomics, Inc.
  • Thermo Fisher Scientific, Inc.

For more information visit


Contact Data